Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma

Human Gene Therapy

Volumn 9, Issue 17, 1998, Pages 2503-2515

  Yoshida, Yoko ^a   Sadata, Akiko ^a   Zhang, Weiping ^a,b   Saito, Kyoko ^a   Shinoura, Nobusada ^a,c   Hamada, Hirofumi ^a  

^a CANCER INSTITUTE   (Japan)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; INTERLEUKIN 12; INTERLEUKIN 2;

ARTICLE; CONTROLLED STUDY; DNA PROTEIN COMPLEX; DNA TRANSFECTION; ESOPHAGUS TUMOR; EXPRESSION VECTOR; FIBROBLAST CULTURE; GENE THERAPY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PLASMID; PROSTATE TUMOR; REPORTER GENE; TUMOR CELL LINE; VIRUS MUTANT;

ADENOVIRIDAE; APOPTOSIS; BASE SEQUENCE; BRAIN NEOPLASMS; CELL LINE; DNA PRIMERS; GENE THERAPY; GLIOMA; HUMANS; INTERLEUKIN-12; INTERLEUKIN-2; MICROSCOPY, ELECTRON; PLASMIDS; RECOMBINATION, GENETIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5;

EID: 0032553646     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349850019346     Document Type: Article

References (40)

1. ANDERSON, W.F. (1998). Human gene therapy. Nature (London) 392(Suppl.), 25-30.
2. BERGELSON, J.M., CUNNINGHAM, J.A., DROGUETT, G., KURT-JONES, E.A., KRITHIVAS, A., HONG, J.S., HORWITZ, M.S., CROWELL, R.L., and FINBERG, R.W. (1997). Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275(5304), 1320-1323.
3. BISCHOFF, J.R., KIRM, D.H., WILLIAMS, A., HEISE, C., HORN, S., MUNA, M., NG, L., NYE, J.A., SAMPSON-JOHANNES, A., FATTAEY, A., and McCORMICK, F. (1996). An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274(5286), 373-376.
4. EWEN, M.E., and MILLER, S.J. (1996). p53 and translational control. Biochim. Biophys. Acta 1242, 181-184.
5. FU, L., MINDEN, M.D., and BENCHMOL, S. (1996). Translational regulation of human p53 gene expression. EMBO J. 15, 4392-4401.
6. GALL, J., KASS-EISLER, A., LEINWAND, L., and FALCK-PEDERSEN, E. (1996). Adenovirus type 5 and 7 capsid chimera: Fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J. Virol. 70(4), 2116-2123.
7. GOMEZ-MANZANO, C., FUEYO, J., KYRITSIS, A.P., STECK, P.A., ROTH, J.A., McDONNELL, T.J., STECK, K.D., LEVIN, V.A., and YUNG, W.K.A. (1996). Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res. 56, 694-699.
8. HEISE, C., SAMPSON-JOHANNES, A., WILLIAMS, A., McCORMICK, F., VON HOFF, D.D., and KIRN, D.H. (1997). ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nature Med. 3(6), 639-645.
9. HONG, J.S., and ENGLER, J.A. (1996). Domains required for assembly of adenovirus type 2 fiber trimers. J. Virol. 70(10), 7071-7078.
10. HONG, S.S., KARAYAN, L., TOURNIER, J., CURIEL, D.T., and BOULANGER, P.A. (1997). Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 16(9), 2294-2306.
11. HOOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B., and HARRIS, C. (1991). p53 mutations in human cancers. Science 253, 49-53.
12. HUDSON, J.M., FRADE, R., and BAR-ELI, M. (1995). Wild-type p53 regulates its own transcription in a cell-type specific manner. DNA Cell Biol. 14, 759-766.
13. IRMLER, M., THOME, M., HAHNE, M., SCHNEIDER, P., HOFMANN, K., STEINER, V., BOOMER, J.L., SCHROTER, M., BURNS, K., MATTMANN, C., RIMOLDI, D., FRENCH, L.E., and TSCHOPP, J. (1997). Inhibition of death receptor signals by cellular FLIP. Nature (London) 388, 190-195.
14. JIANG, W., KAHN, S.M., ZHOU, P., ZHANG, Y.-J., CACACE, A.M., INFANTE, A.S., DOI, S., SANTELLA, R.M., and WEINSTEIN, I.B. (1993). Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8, 3447-3457.
15. KRASNYKH, V.N., MIKHEEVA, G.V., DOUGLAS, J.T., and CURIEL, D.T. (1996). Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J. Virol. 70(10), 6839-6846.
16. KRASNYKH, V., DMITRIEV, I., MIKHEEVA, G., MILLER, C.R., BELOUSOVA, N., and CURIEL, D.T. (1988). Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J. Virol. 72 (3), 1844-1852.
17. LIU, T.J., ZHANG, W.W., TAYLOR, D.L., ROTH, J.A., GOEPFERT, H., and CLAYMAN, G.L. (1994). Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 54, 3662-3667.
18. MICHAEL, S.I., HONG, J.S., CURIEL, D.T., and ENGLER, J.A. (1995). Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther. 2(9), 660-668.
19. MIYAKE, S., MAKIMURA, M., KANEGAE, Y., HARADA, S., SATO, Y., TAKAMORI, K., TOKUDA, C., and SAITO, I. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. U.S.A. 93, 1320-1324.
20. MOSNER, J., MUMMENBRAUER, T., BAUER, C., SCZAKIEL, G., GROSSE, F., and DEPPERT, W. (1995). Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14, 4442-449.
21. NAKAMURA, Y., WAKIMOTO, H., ABE, J., KANEGAE, Y., SAITO, I., AOYAGI, M., HIRAKAWA, K., and HAMADA, H. (1994). Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2. Cancer Res. 54, 5757-5760.
22. NIWA, H., YAMAMURA, K., and MIYAZAKI, J. (1991). Efficient selection for high-expression transtectants with a novel eukaryotic vector. Gene 108, 193-200.
23. v-integrins. Hum. Gene Ther. 9, 507-520.
24. REED, J.C., MIYASHITA, T., TAKAYAMA, S., WANG, H.G., SATO, T., KRAJEWSKI, S., AIME-SEMPE, C., BODRUG, S., KITADA, S., and HANADA, M. (1996). BCL-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell Biochem. 60, 23-32.
25. ROGERS, B.E., DOUGLAS, J.T., AHLEM, C., BUCHSBAUM, D.J., FRINCKE, J., and CURIEL, D.T. (1997). Use of a novel cross-linking method to modify adenovirus tropism. Gene Ther. 4, 1387-1392.
26. ROTH, J.A., NGUYEN, D., LAWRENCE, D.D., KEMP, B.L., CARRASCO, C.H., PERSON, D.Z., HONG, W.K., KOMAKI, R., LEE, J.J., NESBITT, J.C., PISTERS, K.M.W., PUTNAM, J.B., SCHEA, R., SHIN, D.M., WALSH, G.L., DOLORMENTE, M.M., HAN, C.-I., MARTIN, F.D., YEN, N., XU, K., STEPHENS, L.C., McDONNELL, T.J., MUKHOPADHYAY, T., and CAI, D. (1996). Retrovirus-medaited wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Med. 2(9), 985-991.
27. STEVENSON, S.C., ROLLENCE, M., MARSHALL-NEFF, J., and McCLELLAND, A. (1997). Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J. Virol. 71(6), 4782-4790.
28. TOMKO, R.P., XU. R., and PHILIPSON, L. (1997). HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. U.S.A. 94(7), 3352-3356.
29. VAN MEIR, E.G., KIKUCHI, T., TADA, M., LI, H., DISERENS, A.-C. WOJCIK, B.E., SU HUANG, H.-J., FRIEDMANN, T., NICOLAS DE TRIBOLET, and CAVENEE, W.K. (1994). Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res. 54, 649-652.
30. WAKIMOTO, H., YOSHIDA, Y., AOYAGI, M., HIRAKAWA, K., and HAMADA, H. (1997). Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells tor tumor vaccination therapy. Jpn. J. Cancer Res. 88, 296-305.
31. WICKHAM, T.J., CARRION, M.E., and KOVESDI, I. (1995). Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2(10), 750-756.
32. WICKHAM, T.J., SEGAL, D.M., ROELVINK, P.W., CARRION, M.E., LIZONOVA, A., LEE, G.M., and KOVESDI, I. (1996a). Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70(10), 6831-6838.
33. WICKHAM, T.J., ROELVINK, P.W., BROUGH, D.E., and KOVESDKI. I. (1996b). Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nature Biotechnol. 14, 1570-1573.
34. WICKHAM, T.J., TZENG, E., SHEARS II, L.L., ROELVINK, P.W., LI, Y., LEE, G.W., BROUGH, D.E., LIZONOVA, A., and KOVESDI, I. (1997a). Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71(11), 8221-8229.
35. WICKHAM, T.J., HASKARD, D., SEGAL, D., and KOVESDI, I. (1997b). Targeting endothelium for gene therapy via receptors upregulated during angiogenesis and inflammation. Cancer Immunol. Immunother. 45(3-4), 149-151.
36. WICKHAM, T.J., LEE, G.M., TITUS, J.A., SCONOCCHIA, G., BAKACS, T., KOVESDI, I., and SEGAL, D.M. (1997c). Targeted adenovirus-mediated gene delivery to T cells via CD3. J. Virol. 71(10), 7663-7669.
37. WU, X., BAYLE, J.H., OLSON, D., and LEVINE, A.J. (1993). The p53-mdm-2 auto regulatory feedback loop. Genes Dev. 7, 1126-1132.
38. XIA, D., HENRY, L., GERARD, R.D., and DEISENHOFER, J. (1995). Structure of the receptor binding domain of adenovirus type 5 fiber protein. Curr. Topics Microbiol. Immunol. 199(1), 39-46.
39. YAMAMOTO, S., WAKIMOTO, H., AOYAGI, M., HIRAKAWA, K., and HAMADA, H. (1997). Modulation of motility and proliferation of glioma cells by hepatocyte growth factor. Jpn. J. Cancer Res. 88, 564-577.
40. YOSHIDA, Y., and HAMADA, H. (1997). Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal. Biochem. Biophys. Res. Commun. 230, 426-430.